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Tamsyn Jacki Jeffery and Liza Bornman*
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Background: The disparity in prevalence of infectious diseases across the globe is 
common knowledge. Vitamin D receptor (VDR)-mediated toll-like receptor (TLR) 2/1 sig-
naling produces antimicrobial peptides, which is critical as a first line of defense in innate 
immunity. Numerous studies disclosed the independent role of genetic polymorphisms 
in this pathway, vitamin D status or season and more recently epigenetics, as factors 
contributing to infectious disease predisposition. Few studies address the interaction 
between environment, genetics, and epigenetics. Here, we hypothesized that VDR-
mediated TLR2/1 signaling is influenced by a combination of environment, epigenetics 
and genetics, collectively influencing differential innate immunity.
Methods: Healthy Black and White South Africans (n = 100) donated blood, while 
ultraviolet index (UVI) was recorded for the duration of the study. LC-MS/MS supported 
25(OH)D3 quantification. Monocyte/macrophage cultures, supplemented with/without 
1,25(OH)2D3, were activated with the TLR2/1 elicitor, Pam3CSK4. VDR, cathelicidin 
antimicrobial peptide, hCAP-18, and 25-hydroxyvitamin D3-24-hydroxylase expres-
sion were quantified by RT-qPCR or flow cytometry. Pyrosequencing facilitated VDR 
methylation analysis and single-nucleotide polymorphism (SNP) genotyping in regions 
pinpointed through a bioinformatics workflow.
results: Season interacted with race showing 25(OH)D3 deficiency in Blacks. UVI 
correlated with 25(OH)D3 and VDR methylation, likely influencing race differences in the 
latter. Regarding the TLR2/1 pathway, race differences in SNP genotype distribution 
were confirmed and functional analysis of VDR-mediated signaling showed interaction 
between race, season, and 25(OH)D3 status. Multivariate OPLS-DA mirrored several 
interactions between UVI, 25(OH)D3 status, DNA sequence, and methylation variants. 
Methylation of the third cytosine-phosphate-guanine dinucleotide (CpG) in the pro-
moter CpG island (CGI) 1062, CGI 1062 CpG 3, significantly discriminated a 5.7-fold 
above average mean in VDR protein level upon TLR2/1 elicitation, the variation of 
which was further influenced by 25(OH)D3 status and the VDR SNP TaqI.
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conclusion: Regulation of VDR-mediated TLR2/1 signaling is multifactorial,
involving interaction between environment [UVI and consequent 25(OH)D3 status],
epigenetics (VDR methylation at key regulatory sites), and genetics (TLR1, TIRAP, 
and VDR SNPs).
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inTrODUcTiOn
In addition to its role in maintaining calcium–phosphorus 
homeostasis, vitamin D is a potent modulator of both innate 
and adaptive immunity, is involved in the regulation of cell 
growth and differentiation, detoxification of xenobiotics, and 
activation of monocytes/macrophages (1, 2). These actions 
of vitamin D are almost entirely dependent on the interac-
tion between the most biologically active form of vitamin D, 
1,25-dihydroxyvitamin D3 [1,25(OH)2D3], and the vitamin D 
receptor (VDR) transcription factor. Bound to 1,25(OH)2D3, 
the VDR regulates the expression of a myriad of genes (3, 4). 
Cathelicidin antimicrobial peptide (CAMP) and 25-hydroxy-
vitamin D3-24-hydroxylase (CYP24A1) are examples of two 
well-characterized vitamin D target genes, respectively, encod-
ing the cathelicidin antimicrobial peptide (hCAP-18) and 
multifunctional vitamin D catabolizing enzyme.
Toll-like receptor 2/1 (TLR2/1) triggering activates a 
signaling cascade inducing both VDR (5) and CYP27B1 in 
monocytes/macrophages. CYP27B1 catalyzes de novo produc-
tion of 1,25(OH)2D3 from accumulated 25(OH)D3; delivered 
to the cells via the vitamin D binding protein (DBP), encoded 
by GC. The liganded VDR–transcription factor complex binds 
to vitamin D response elements (VDREs) in CAMP, activating 
CAMP expression and the production of hCAP-18. hCAP-18 is 
synthesized as a proprotein consisting of an N-terminal cathelin 
domain and a C-terminal LL-37 domain (6). While the cathelin 
domain is a cysteine protease inhibitor with broad spectrum 
antibacterial activity (7), LL-37 directly inhibits mycobacte-
rial replication (5, 8), has antifungal activity against Candida 
albicans (9), and antiviral activity against HIV (10).
Since CAMP expression is dependent on vitamin D, and vita-
min D deficiency has been linked to several infectious diseases 
including tuberculosis (11), sepsis (12), bacterial infections after 
kidney transplants (13), and HIV (14), it is not surprising that 
more than 100 clinical trials have assessed the efficacy of vitamin 
D supplementation as adjunct therapy in the treatment of vari-
ous infectious diseases. However, the outcome of clinical trials 
has been conflicting and this is often attributed to differences 
in study design, baseline vitamin D status of participants, and 
outcome measurements. In fact, it appears that individuals can 
be classified into three groups: (i) those with a low response, 
(ii) those with a medium response, and (iii) those with a high 
response to vitamin D supplementation (15). These interindi-
vidual differences may result from variation in the regulation 
of VDR expression at both a genetic and epigenetic level (16). 
For example, VDR function to transactivate CAMP is influ-
enced by the VDR single nucleotide polymorphism (SNP) FokI 
(rs2228570) and ethnicity (17), while vitamin D insensitivity in 
breast cancer cells has been attributed to CpG methylation of the 
VDR primary promoter (18). Thus, both genetics and epigenet-
ics have the potential to influence the response to vitamin D. 
Indeed, a double-blind randomized controlled trial assessing 
the impact of high-dose vitamin D3 during intensive-phase 
antimicrobial treatment of pulmonary tuberculosis showed that 
vitamin D only increased the time for sputum culture conversion 
in participants carrying the CC genotype of the VDR SNP TaqI 
(rs731236) (19). Additionally, VDR expression is influenced 
by the environment. For example, narrow-band UVB induces 
miRNA-125b (20), which directly regulates VDR mRNA transla-
tion, decreasing VDR protein level (21, 22). Seasonal variation 
in ultraviolet index (UVI) further correlates with circulating 
vitamin D (23). Thus, seasonal variation in UVI directly influ-
ences VDR function by altering the availability of the free 
1,25(OH)2D3. Indirectly, changes in 1,25(OH)2D3 concentration 
may itself regulate VDR expression through multifunctional, 
1,25(OH)2D3-responsive, enhancers located within the VDR 
itself (24). The complex regulation of the VDR through genetics, 
epigenetics, and environment (16) may therefore provide insight 
into inter-individual variation in response to vitamin D and the 
efficacy of vitamin D to enhance immune function.
Here, we evaluate (1) the effect of VDR methylation on the 
TLR2/1-VDR signaling pathway and (2) the impact of genetic 
and environmental factors on differential immune signaling. It 
was hypothesized that VDR-mediated TLR2/1 signaling is influ-
enced by a combination of environment, epigenetics and genetics, 
collectively influencing differential innate immunity in healthy 
South Africans. Using an in vitro model, stimulating monocytes 
from healthy individuals with a TLR2/1 elicitor, we avoided 
pathogen-mediated changes in DNA methylation (25, 26).
Results presented here provide support for multifactorial 
regulation of VDR-mediated, TLR2/1 signaling, involving inter-
action between environment, epigenetics, and genetics. UVI 
Abbreviations: CAMP, cathelicidin antimicrobial peptide; CGI, CpG island; 
CpG, Cytosine-phosphate-guanine dinucleotide; CYP cytochrome P-450 enzyme; 
CYP24A1, 25-hydroxyvitamin D3-24-hydroxylase; DBP, vitamin D-binding pro-
tein; GC, group-specific component; hCAP-18, human cathelicidin antimicrobial 
peptide 18 kDa; IOM, Institute of Medicine; LL-37, cathelicidin antimicrobial 
peptide fragment; 1,25(OH)2D3, 1,25-dihydroxycholecalciferol; 25(OH)D3, 
25-hydroxycholecalciferol; NF-κB, nuclear factor kappa B; OPLS-DA, Orthogonal 
projections to latent structures discriminant analysis; Pam3CSK4, synthetic 
triacylated lipopeptide; N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-
[R]-cysteinyl-[S]-seryl-[S]-lysyl-[S]-lysyl-[S]-lysyl-[S]-lysyl  ×  3HCL; SANBS, 
South African National Blood Service; SNP, single-nucleotide polymorphism; 
TiRAP, toll-interleukin 1 receptor (TIR) domain-containing adaptor protein; TLR, 
toll-like receptor; UVB, ultraviolet B rays; UVI, ultraviolet index; VDR, vitamin 
D receptor.
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influences 25(OH)D3 status, which regulates VDR expression 
through VDR methylation, while enhancing the extent and rate 
of VDR transactivation of CAMP encoding the antimicrobial 
peptide hCAP-18.
MaTerials anD MeThODs
sample collection and environment
In accordance with the Declaration of Helsinki, the Human 
Research Ethics Committee of the South African National Blood 
Service (SANBS HREC clearance certificate number 2010/01) 
and the Ethics Committee, Faculty of Science, University of 
Johannesburg (2010/06/03) approved the study. After written 
informed consent, the SANBS collected blood from randomly 
selected healthy Black (n = 50; age 17–62 years; 25 males and 
25 females) and White (n = 50; age 17–69 years; 25 males and 
25 females) South Africans living in Gauteng, SA. Samples were 
collected across all seasons, though no White individuals were 
collected in winter for functional analysis. UVI was obtained 
from the South African Weather Service weather station in Irene, 
Pretoria, Gauteng. As 25(OH)D3 has a half-life of 2–4  weeks 
in circulation (27), the approximate UVI that each individual 
could have been exposed to was calculated as the 4-week average 
before blood collection, using the average hourly UVI between 
11.00 a.m. and 14.00 p.m. across the years of sample collection 
(2011–2014).
Quantification of circulating 25(Oh)D3
Liquid chromatography tandem mass spectrometry (LC-MS/
MS) facilitated quantification of 25(OH)D3 concentration in 
the Department of Clinical Biochemistry, University Hospital 
of South Manchester (UK), including four human serum pools 
from the Vitamin D External Quality Assessment Scheme 
(DEQAS, UK). A concentration of ≥50 nmol/L was considered 
normal/sufficient (28). 25(OH)D3 concentration was below the 
detection limit (3 nmol/L) in four Black samples, while sample 
was insufficient for six Blacks and eight Whites.
Bioinformatics
To identify putative functional loci that could influence VDR 
expression and function through genetic and/or epigenetic 
mechanisms, a bioinformatics workflow was developed 
(Methods S1.1, Figures S1 and S2, and Table S1 in Supplementary 
Material).
Dna Methylation analysis
Monocytes were isolated and gDNA extracted, at time zero, as 
previously described (17). VDR methylation analysis by bisulfite 
pyrosequencing was outsourced to EpigenDx, Inc. (MA, USA). 
Selected sites typed included 10 CpGs in CpG island (CGI) 
1066 spanning enhancer U3 (chr12:48340628-48340806, 
hg19), 56 CpGs in CGI 1062 spanning the primary promoter 
(chr12:48299359-48298799), 12 CpGs in CGI 1061 spanning 
exon 3 (chr12:48258845-48259024), and 18 CpGs in CGI 1060 
spanning exon 9 (chr12:48238512-48238799). CpGs were num-
bered in the 5′–3′ direction.
genotyping
Genotyping by pyrosequencing was outsourced to EpigenDx, 
Inc. (MA, USA). Typed SNPs included GC rs7041, rs4588, 
and rs146681395; TLR1 rs5743551 (A7202G), rs146940675, 
rs4833095 (N248S), rs111807776, rs143576765, rs5743618 
(I602S), rs151036585, rs5743613 (P315L), rs185747096, 
rs146782074, and rs200631178; TLR2 rs3804099 (T597C); 
TiRAP rs8177374 (S180L) and rs141792148; VDR rs11168312, 
rs11568820 (Cdx-2), rs182743714, rs184448883, rs4516035 
(GATA), rs2228570 (FokI), rs187018098, rs71951818, 
rs1544410 (BsmI), rs7975232 (ApaI), rs731236 (TaqI), and 
rs4987032; CYP24A1 rs6068812; and DMNT3A rs1550117 and 
rs112621472.
Monocyte/Macrophage culture and 
Treatment
To estimate TLR2/1 pathway efficacy, VDR mRNA, VDR protein, 
CAMP mRNA, hCAP-18 peptide, and CYP24A1 mRNA, hereaf-
ter referred to as functional variables, were quantified following 
different treatments of monocyte/macrophage cultures that were 
established as previously described (17). Some monocytes were 
retained for functional analysis at time zero (baseline). The rest 
were settled in culture for 16 h prior to 24 h treatment with the 
vehicle control, 1,25(OH)2D3 (10 nM, Sigma Aldrich, St Louis, 
MO, USA), the TLR2/1 elicitor Pam3CSK4, (6.5  µg/ml culture 
media, EMC microcollections, Tuebingen, Germany), or both 
the elicitor and 1,25(OH)2D3.
mrna and Protein Quantification
The relative level of VDR, CAMP, and CYP24A1 mRNA was 
quantified by RT-qPCR and VDR protein and intracellular 
hCAP-18 peptide by flow cytometry as previously described 
(17). Gene normalization was performed against two stably 
expressed reference genes: ubiquitin C (UBC) and tyrosine-
3-monooxygenase/tryptophan-5-monooxygenase activation 
protein, zeta polypeptide (YWHAZ). Gene expression was 
quantified using the comparative CT method according to the 
MIQE guidelines, using inter-run calibrators and qBASEPLUS 
software. To compensate for variability in fluorescence readings 
between experiments on the flow cytometer, the median fluo-
rescence intensity (MFI) of broad-spectrum calibration beads 
was used to normalize data and thereby provide a calibrator 
for instrument-related variation in the flow cytometry readings 
over time. For hCAP-18, mouse IgG1 anti-human hCAP-18 
primary antibodies (10  µg/ml, Abcam, Cambridge, UK) and 
APC-conjugated goat anti-mouse IgG1 secondary antibodies 
(2 µg/mL, Abcam, Cambridge, UK) were used. Western blot-
ting facilitated tracing of hCAP-18 processing and secretion 
(Methods S1.2 in Supplementary Material).
statistical analysis
IBM® SPSS® Statistics (v 23; SPSS Inc., Chicago, IL, USA) and 
SIMCA (v 14; Umetrics, Umea, Sweden) facilitated statisti-
cal analysis. Normal distributions were obtained by natural 
logarithm (ln) transformation of all functional data, except 
VDR protein. Correlation coefficients were computed using 
FigUre 2 | Race differences in regional vitamin D receptor (VDR) methylation. Box-and-whisker plots show the spread of regional methylation, quantified by bisulfite 
pyrosequencing, at the selected CpG islands (CGIs) (a) in context of VDR non-coding (unfilled) and coding exons (filled) and key single-nucleotide polymorphisms 
(B); CGI 1066 spanning an enhancer, 1062 the primary promoter, 1061 exon 3 and 1060 exon 9, and the promoter of a non-coding transcript. Compared to Black 
South Africans (filled boxes, n = 50), methylation in Whites (open boxes, n = 50) was significantly lower in CGI 1062 (***P < 0.001) and 1060a (**P < 0.010), but 
higher in CGI 1060b (***P < 0.001). Box-and-whisker plots show the median (line in box), interquartile range (IQR, height of box), 95% CI (whiskers, extending to 1.5 
IQRs or minimum and maximum values if no case has a value in that range), outliers (○, between 1.5 IQRs and 3 IQRs from the end of a box), and extreme outliers 
(◻, more than 3 IQRs from the end of a box). Site-specific methylation is shown in Figures S5A–D in Supplementary Material.
FigUre 1 | Race and season influenced plasma 25(OH)D3 concentration. 
The error bar plot shows the mean plasma 25(OH)D3 concentration, 
quantified by liquid chromatography tandem mass spectrometry, for healthy 
Black (filled markers, n = 50) and White (open markers, n = 53) South 
Africans, collected in winter (Black n = 17, White n = 10), spring (Black 
n = 10, White n = 16), summer (Black n = 10, White n = 11), and autumn 
(Black n = 13, White n = 16). Blacks were deficient (<50 nmol/L), having a 
significantly lower plasma 25(OH)D3 concentration than Whites in winter 
(*P < 0.050), spring (***P < 0.001), and overall (**P < 0.010). Overall, whites 
had normal 25(OH)D3 levels (≥50 nmol/L, ≤125 nmol/L), with a significantly 
higher plasma 25(OH)D3 concentration in spring compared to autumn 
(+P < 0.050). P-Values were adjusted using Bonferroni correction. Error bars 
show the unadjusted least significant difference at P < 0.050. The dotted line 
indicates the border between normal and deficient.
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Pearson or Spearman’s rho. A general linear model was used for 
multivariate analysis of variance to assess main effects and factor 
interaction. Mann–Whitney U tested methylation differences. 
Pearson’s Chi-square test for independence assessed SNP distri-
bution. Orthogonal projections to latent structures discriminant 
analysis (OPLS-DA, Methods S1.3 and Figures S3 and S4 in 
Supplementary Material) facilitated the study of the multivariate 
effect of VDR methylation, SNPs, and environment on TLR2/1-
VDR signaling.
resUlTs
Differences in Plasma 25(Oh)D3 
concentration are influenced by  
race and season
Plasma 25(OH)D3 concentration was quantified by LC-MS/MS 
(Figure  1). Race had a significant main effect on 25(OH)D3  
concentration (P  <  0.001). Overall, Blacks were deficient 
(<50  nmol/L) with a significantly lower 25(OH)D3 con-
centration (P <  0.010) than Whites, who had normal levels 
(≥50  nmol/L). Race interacted significantly with season 
(P  <  0.010), showing a lower 25(OH)D3 concentration in 
Blacks in winter (P < 0.050) and spring (P < 0.001), but not in 
summer and autumn.
VDR Methylation Differs between races
To assess the impact of VDR methylation on TLR2/1-VDR 
signaling, VDR methylation was quantified by bisulfite pyrose-
quencing. Regional methylation (Figure  2A) was compared 
between Blacks and Whites across the VDR in key CGIs 
TaBle 1 | Differential genotype distribution for polymorphic single-nucleotide polymorphism (SNPs) in the toll-like receptor (TLR)–vitamin D receptor (VDR) pathway in 
Black and White South Africans.
gene genotypea Black White Pearson’s chi-square
Polymorphism (common name)  number (%) number (%) χ2 df P-value cramer’s V b
GC
rs7041 GG 1 (2) 10 (22) 60 2 <0.001 0.806
GT 2 (4) 30 (65)
TT 43 (93) 6 (13)
rs4588 AA 2 (4) 1 (2) 8 2 <0.050 0.298
AC 6 (13) 18 (39)
CC 38 (83) 27 (59)    
TLR1
rs5743551 (A7202G) AA 1 (2) 26 (53) 61 2 <0.001 0.790
AG 6 (12) 19 (39)
GG 43 (86) 4 (8)
rs4833095 (N248S) AA 2 (4) 24 (52) 43 2 <0.001 0.684
AG 9 (20) 19 (37)
GG 34 (76) 5 (11)
rs5743618 (I602S) CC 0 (0) 0 (0) 57 1 <0.001 0.796
CA 2 (4) 40 (83)
AA 45 (96) 8 (17)
TLR2
rs3804099 (T597C) CC 28 (64) 12 (25) 21 2 <0.001 0.484
CT 15 (34) 22 (47)
 TT 1 (2) 13 (28)
TIRAP
rs8177374 (S180L) AA 0 (0) 1 (2) 16 2 <0.001 0.402
AG 1 (2) 15 (31)
GG 47 (98) 33 (67)    
VDR
rs11568820 (Cdx-2) AA 25 (57) 3 (6) 43 2 <0.001 0.683
AG 17 (39) 14 (29)
GG 2 (5) 31 (65)
rs4516035 (GATA) AA 44 (90) 16 (33) 34 2 <0.001 0.587
AG 4 (8) 28 (57)
GG 1 (2) 5 (10)
rs2228570 (FokIc) TT/ff 2 (4) 12 (24) 17 2 <0.001 0.413
TC/Ff 12 (25) 21 (43)
CC/FF 35 (71) 16 (33)
rs1544410 (BsmI) AA/BB 2 (4) 8 (16) 4 2 ns 0.213
AG/bB 21 (43) 20 (42)
GG/bb 26 (53) 20 (42)
rs7975232 (ApaI) TT/AA 27 (55) 13 (27) 12 2 <0.010 0.351
TG/Aa 21 (43) 27 (55)
GG/aa 1 (2) 9 (18)
rs731236 (TaqI) TT/TT 21 (43) 21 (43) 2 2 ns 0.152
TC/Tt 23 (47) 18 (37)
CC/tt 5 (10) 10 (20)    
aAlleles used in genotypes represent those of the reverse strand on which the gene is located.
bCramer’s V indicates effect size and varies between 0 and 1: small 0.07–0.20, medium 0.21–0.34, and large 0.35–1.00.
cFokI, BsmI, ApaI, and TaqI genotypes show nucleotides/restriction sites presence (lowercase) or absence (capital).
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identified through a bioinformatics workflow (Methods S1.1, 
Figures S1 and S2, and Table S1 in Supplementary Material). 
Comparing regional methylation, Whites had significantly 
lower levels at CGI 1062 (P < 0.001) and CGI 1060a (CpG 1-5, 
5′ of TaqI, Figure 2A, P < 0.010) than Blacks, but higher levels 
at CGI 1060b (CpG 7-18, 3′ of TaqI, Figure  2A, P <  0.001). 
Significant racial differences in site-specific methylation 
(Results S2.2 and Figure S5 in Supplementary Material) were 
common in CGI 1062 (27/56) and 1060 (10/18), but less so in 
CGI 1066 (1/10) and1061 (3/12).
Tlr-VDr Pathway genetics Differs 
between races
To assess genetic variation between individuals in the TLR2/1-
VDR signaling pathway, SNPs in several genes of the pathway 
TaBle 2 | Multivariate main and interaction effects of season, race, 25(OH)D3 status, and treatment on the functional variables marking TLR2/1 vitamin D receptor 
(VDR)-mediated signaling.
Multivariate 
P-valuea
Tests of between-subjects
independent variable ln VDR mrna VDr protein ln CAMP mrna ln hcaP-18 
peptide
ln CYP24A1 mrna
Season 0.000*** 0.089 0.003** 0.000*** 0.000*** 0.000***
Race 0.000*** 0.146 0.617 0.000*** 0.000*** 0.000***
25(OH)D3 status 0.135 na.b na. na. na. na.
Treatment 0.000*** 0.999 0.000*** 0.000*** 0.385 0.000***
Season × race 0.000*** 0.000*** 0.000*** 0.010* 0.000*** 0.543
Season × 25(OH)D3 status 0.000*** 0.024* 0.055 0.259 0.001** 0.000***
Season × treatment 1.000 na. na. na. na. na.
Race × 25(OH)D3 status 0.000*** 0.866 0.346 0.092 0.000*** 0.001**
Race × treatment 0.957 na. na. na. na. na.
25(OH)D3 status × treatment 0.999 na. na. na. na. na.
Season × race × 25(OH)D3 status 0.002** 0.001** 0.848 0.530 0.069 0.012*
Season × race × treatment 1.000 na. na. na. na. na.
Season × 25(OH)D3 status × treatment 1.000 na. na. na. na. na.
Race × 25(OH)D3 status × treatment 0.919 na. na. na. na. na.
Season × race × 25(OH)D3 status × treatment 0.998 na. na. na. na. na.
Levene’sc  0.093 0.121 0.080 0.598 0.004**
aMultivariate Pillai’s trace statistic is significant at *P < 0.050, **P < 0.010, and ***P < 0.001.
bna. Not applicable for testing due to multivariate P > 0.050.
cLevene’s Test of Equality of Error Variances is significant at **P < 0.010.
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and in the de novo methyltransferase enzyme, DNMT3A, 
were genotyped by pyrosequencing. Several SNPs, including 
DNMT3A SNPs, were monomorphic in the study population. 
Except for VDR BsmI and TaqI, the frequency distribution of 
polymorphic SNPs differed significantly between Blacks and 
Whites (Table 1). The 1000 Genomes Deep Catalog of Human 
Genetic Variation confirmed race-specific genotype frequency 
distribution, also for BsmI and TaqI though not for ApaI, 
comparing Africans (Yoruba) and Caucasians (Table S2 in 
Supplementary Material).
Multivariate effects of race, Plasma 
25(Oh)D3 status, season, and Treatment 
on Functional Variables upon elicitation of 
Tlr2/1-VDr signaling
To assess the efficacy of the TLR2/1-VDR signaling regarding 
functional variables in the pathway (VDR mRNA, VDR protein, 
CAMP mRNA, hCAP-18, and CYP24A1 mRNA), multivariate 
analysis of the effect of race, 25(OH)D3 status, season, and 
treatment (with/without in vitro 1,25(OH)2D3 supplementation 
and/or TLR2/1 elicitation) was performed (Table 2). Treatment 
had a significant main effect on functional variables (Figure 3), 
while season, race, and 25(OH)D3 status showed several 
complex interactions regarding VDR mRNA and VDR protein 
(Figure  4), CAMP mRNA and CYP24A1 mRNA (Figure  5) 
and hCAP-18 (Figure  6). TLR2/1 elicitation induced VDR 
protein (Figure  3B, P <  0.001), while 1,25(OH)2D3 induced 
CAMP mRNA and CYP24A1 mRNA (Figures 3C,E, P < 0.001). 
Considering interactions, 25(OH)D3-deficient Blacks had sig-
nificantly lower VDR mRNA in summer than deficient Whites 
or Whites and Blacks with a normal 25(OH)D3 status (P < 0.050, 
Figure  4A). In contrast, 25(OH)D3-deficient Whites had sig-
nificantly lower VDR mRNA in autumn than deficient Blacks or 
Whites and Blacks with a normal 25(OH)D3 status (P < 0.050). 
VDR protein dropped significantly in summer and autumn 
for Whites and Blacks, respectively, showing a significant race 
difference in summer (P <  0.050, Figure  4B). CAMP mRNA 
increased significantly from summer to autumn in Whites, 
being significantly higher than Blacks (P < 0.050, Figure 5A). 
Whites with a normal 25(OH)D3 status had significantly higher 
CYP24A1 mRNA than 25(OH)D3-deficient Whites or Blacks and 
Blacks with a normal 25(OH)D3 status (P < 0.050, Figure 5B). 
A notable decrease in hCAP-18 was observed in Whites from 
spring through summer to autumn being significantly higher in 
spring and significantly lower in autumn, compared to Blacks 
(P < 0.050, Figure 6A). All individuals with a normal 25(OH)D3 
status showed a similar, significant decrease in hCAP-18 from 
spring to autumn (P < 0.050, Figure 6B). Blacks with a normal 
25(OH)D3 status had significantly more hCAP-18, than normal 
Whites and deficient Blacks or Whites (P < 0.050, Figure 6C). 
To confirm that the intracellular decrease in hCAP-18 in 
response to seasons with higher 1,25(OH)2D3 reflects hCAP-18 
processing and LL-37 secretion, we performed Western blotting 
on 20 additional randomly selected healthy Black (n = 10) and 
White (n = 10) South Africans. These individuals, collected in 
winter and for whom no other variables were quantified, were 
also included in 25(OH)D3 quantification (shown in Figure 1). 
Western blotting showed individual-specific hCAP-18 pro-
cessing and LL-37 secretion, which depended on 25(OH)D3 
status, extent of 1,25(OH)2D3 supplementation, and incubation 
time (Figure  7). For example, an individual with a sufficient 
25(OH)D3 status (>50 nmol/L, Figure  7A) had the highest 
level of intracellular LL-37 under control condition and already 
FigUre 3 | Differential vitamin D receptor (VDR)-mediated innate immune 
response to toll-like receptor (TLR) 2/1 elicitation, with or without in vitro 
1,25(OH)2D3 supplementation. The error bar plots show mean levels  
for VDR mRNA (a), VDR protein (B), CAMP mRNA (c), hCAP-18 peptide 
(D), and CYP24A1 mRNA (e), for healthy South Africans (n = 100). Gene 
expression (mRNA) was quantified by RT-qPCR and protein or peptide level 
by flow cytometry. Significant treatment effects are shown (***P < 0.001). All 
significant differences were maintained after Bonferroni correction. Error bars 
show the least significant difference at P < 0.050.
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secreted LL-37 upon TLR2/1 elicitation at 16  h, and secreted 
even more with moderate 1,25(OH)2D3 supplementation 
(10 nM) or at 24 h. However, with excessive (50 nM) supple-
mentation, the individual secreted less (16 h) or none (24 h). In 
contrast, 25(OH)D3-deficient individuals secreted LL-37 slower 
and required at least 50 nM of 1,25(OH)2D3 to secrete at 16 h 
(Figure  7C). An individual with severe 25(OH)D3 deficiency 
(23.2  nmol/L) secreted LL-37 only after 24  h in the presence 
of 50  nM 1,25(OH)2D3 (Figure  7D). It should be noted that 
secreted LL-37 was undetectably low in 13 of the 20 randomly 
selected individuals subjected to Western blotting.
correlation analysis
To further explore the relation between independent variables 
(UVI, 25(OH)D3 concentration, age and regional methylation) 
and dependent functional variables, following different treat-
ments, correlation analysis was performed (Table  3). UVI 
correlated moderately with circulating 25(OH)D3, which in 
turn showed a moderate, negative correlation with regional 
methylation of the VDR promoter CGI 1062. Regarding inter-
CGI correlations, CGI 1066 and 1060b correlated negatively 
with CGI 1062, 1061, and 1060a. The significant correlation 
between 25(OH)D3 and methylation was maintained irrespec-
tive of season, with partial correlations controlling for seasonal 
changes in UVI yielding similar correlation coefficients (data not 
shown). Considering functional variables, regional methylation 
showed moderate correlation with VDR protein under certain 
treatments: CGI 1066 and 1060b (positive for all treatments 
but baseline); 1060a (negative for all treatments but baseline); 
1062 and 1061 (negative for 1,25(OH)2D3 and/or TLR2/1 elici-
tor). As expected, each functional variable showed correlation 
between all treatments (not shown). In addition, VDR mRNA 
showed a number of moderate positive correlations with CAMP 
mRNA, across a number of treatments, similarly so, CAMP with 
CYP24A1 mRNA. Age showed a moderate negative correlation 
with hCAP-18 peptide with TLR2/1 elicitor  +  1,25(OH)2D3  
(r = −0.330, P < 0.01, n = 99).
The combined impact of genetics, 
epigenetics, and environment on  
Tlr2/1-VDr signaling
To identify the main variables underlying differential levels of 
VDR and downstream targets (CAMP, hCAP-18, and CYP24A1), 
the multivariate OPLS-DA statistical method was performed 
and validated as described (Methods S1.3 in Supplementary 
Material). Evaluation of the loadings S-plots (Methods S1.3 and 
Figure S4 in Supplementary Material) and descriptive assess-
ment of the scores space for each model, identified combined 
effects of genetics, VDR methylation, vitamin D status, and UVI 
on the efficacy of TLR2/1-VDR signaling, as assessed by the 
level of functional variables produced in response to various 
treatments. Functional variables were categorized as above/
below average and X (independent) variables that significantly 
(P  ≤  0.050) and/or measurably (≥1.5-fold or ≤0.667) dis-
criminate mean values for above/below average response were 
recorded with their correlation (Table 4). Methylation at CGI 
1062, CpG 3 significantly and most notably discriminate mean 
values for above and below average VDR protein level, particu-
larly with TLR2/1 elicitation. Other sizeable methylation–function 
interactions observed that were significant and occurred in 
at least two treatments of a functional variable included 1060 
CpG 6 [positive impact on VDR mRNA with 1,25(OH)2D3 
FigUre 5 | Interaction between season, race, and 25(OH)D3 status influence vitamin D receptor (VDR) transactivation of cathelicidin antimicrobial peptide (CAMP) 
and 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1). The line graphs show the interaction effects for CAMP mRNA (a) and CYP24A1 mRNA (B) level, quantified 
by RT-qPCR, in monocytes/macrophages from healthy Black (n = 34) and White (n = 41) South Africans. Season and race interacted significantly to influence 
CAMP mRNA (P < 0.050), while season, race, and 25(OH)D3 status showed interaction effects on CYP24A1 mRNA levels (P < 0.050). Error bars show the least 
significant difference at P < 0.050. nc. = not collected.
FigUre 4 | Interaction between season, race, and 25(OH)D3 status influence vitamin D receptor (VDR) mRNA and protein level. The line graphs show the interaction 
effects for VDR mRNA (a) and protein (B) level, quantified by RT-qPCR and flow cytometry, in monocytes/macrophages from healthy Black (n = 34) and White 
(n = 41) South Africans. Season, race, and 25(OH)D3 status interacted significantly to influence VDR mRNA (P < 0.001), while season and race showed interaction 
effects on VDR protein (P < 0.001). Error bars show the least significant difference at P < 0.050. nc. = not collected.
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supplementation or TLR2/1 elicitation], 1062 CpG 23 (negative 
impact on hCAP-18 at control and elicitation, with or without 
supplementation), and CGI 1060a across several neighboring 
CpGs [1060 CpG 1-5, negative impact for 1,25(OH)2D3 sup-
plementation, TLR2/1 elicitation or both, clustering by 25(OH)
D3 status in the absence of supplement and by the TaqI VDR 
SNP with/without supplement]. Methylation at CGI 1066, CpG 
1-6 also influenced VDR protein level positively following 
1,25(OH)2D3 treatment, with or without TLR2/1 elicitor, show-
ing clustering based on race and SNPs in VDR (BsmI, ApaI, 
and TaqI), TLR1 (I602S), and TIRAP (S180L), particularly in 
the presence of supplement. Compared to VDR protein, CAMP 
mRNA level was inversely impacted by CGI 1066, CpG 1-6 
methylation, following 1,25(OH)2D3 treatment, while it clus-
tered only based on 25(OH)D3 status and TaqI. Methylation 
of the CpG located at TaqI was the only methylation site with 
significant impact on VDR mRNA level following 1,25(OH)2D3 
or TLR2/1 elicitor, but not both. Considering environmental 
factors, UVI and 25(OH)D3 significantly influenced VDR 
mRNA level following treatment with 1,25(OH)2D3, TLR2/1 
elicitor, or both. VDR protein level at baseline and CAMP and 
CYP24A1 mRNA upon elicitation were significantly influenced 
by 25(OH)D3. 25(OH)D3 status and TaqI most consistently 
showed clustering during descriptive assessment of the scores 
space of computed models. Model construction for hCAP-18 
was less favorable and we were unable to identify clustering. 
Clustering by season, although tested, was not observed.
DiscUssiOn
Using a healthy South African cohort, we studied the combined 
effect of VDR methylation, TLR2/1-VDR pathway SNPs, and 
environment on TLR2/1 signaling and inter-individual variation 
in the response to vitamin D supplementation.
FigUre 6 | Interaction between season, race, and 25(OH)D3 status influence intracellular hCAP-18 peptide level. The line graphs show the interaction effects for 
hCAP-18 peptide level, quantified by flow cytometry, in monocytes/macrophages from healthy Black (n = 34) and White (n = 41) South Africans. Season and race 
[(a), P < 0.001], season, and 25(OH)D3 status [(B), P < 0.010], and race and 25(OH)D3 status [(c), P < 0.001] interacted significantly to influence hCAP-18 levels. 
Error bars show the least significant difference at P < 0.050. nc. = not collected.
9
Meyer et al. TLR2/1-VDR Signaling Efficacy
Frontiers in Immunology | www.frontiersin.org September 2017 | Volume 8 | Article 1048
Results support race-related seasonal variation in 
25(OH)D3 status (29), though, on average, Blacks were 
25(OH)D3 deficient irrespective of season (Figure 1). Since 
TLR2/1-VDR signaling to induce CAMP greatly depends 
on the availability of 1,25(OH)2D3, Black South Africans 
may have an overall weaker immune response to bacterial 
pathogens and may benefit from vitamin D supplementation 
all year round. However, 25(OH)D3, season, and race showed 
complex interactions that influence TLR2/1-VDR signal-
ing, rendering blanket supplementation presumptuous. For 
example, not all Blacks in the current study were 25(OH)D3 
deficient (14% were sufficient). Western blotting of secreted 
LL-37 showed a decreased LL-37 secretion upon supplemen-
tation of 25(OH)D3 sufficient individuals (Figure  7), sup-
porting the proposed U-shaped relationship between serum 
25(OH)D3 and health (30).
As expected for regional methylation of expressed genes 
(31), VDR enhancer (1066) and promoter (1062) CGIs were 
hypomethylated, while the gene-body CGIs (1061 and 1060) 
were hypermethylated (Figure  2). Blacks had significantly 
higher methylation at CGI 1062 and CGI 1060a, but lower 
methylation at 1060b than Whites. The race-specific variation 
in methylation observed here agrees with Heyn et al. (32) and 
Adkins et  al. (33) who independently showed genome-wide 
methylation differences between populations, contributing 
to natural variation. Similarly, Andraos et  al. (34) showed 
significantly higher methylation levels in the Nigerian Yoruba 
population compared to European Caucasians at several CpG 
sites within VDR CGI 1060. CGI 1060 spans key features; 
the 5′ splice site for exon 9 (partly encoding the ligand bind-
ing domain for VDR), TaqI/CpG 6 embedded in a putative 
VDRE (35) and the promoter of an untranslated transcript 
(AK024830) for which the transcription start site is a few bp 
downstream of a miRNA-125b target site. Thus, differential 
methylation within this region of the VDR may have profound 
effects on the expression of VDR and subsequent efficacy of the 
TLR2/1-VDR signaling pathway. Indeed, we have previously 
shown ethnicity-dependent methylation of VDR CGI 1060 to 
distinguish tuberculosis cases from controls (34).
The significant correlation between VDR methylation and 
plasma 25(OH)D3 supports the proposed relationship between 
vitamin D and the epigenome (36–39). The inverse relationship 
between vitamin D and VDR methylation, especially at the pri-
mary promoter-spanning CGI 1062, suggests that in addition to 
the decrease in ligand, increased promoter methylation may be 
present in vitamin D-deficient individuals, further dampening 
the TLR2/1-VDR signal. Thus, vitamin D may interact with the 
epigenome to influence immune function. Indeed, the higher 
the methylation at CGI 1062 and 1060a, the less VDR protein 
is present in response to 1,25(OH)2D3 supplementation and/or 
TLR2/1 elicitation (Table 3).
Besides epigenetic differences, SNP frequency distribution 
for all, except VDR BsmI and TaqI, differed significantly between 
races with large effect sizes observed for GC rs7041, TLR1 
FigUre 7 | The rate of hCAP-18 processing and secretion is individual-specific and 1,25(OH)2D3-dependent. The Western blots and accompanying line graphs 
(densitometry results) show the relative levels of hCAP-18 (15 kDa) and LL-37 (4 kDa) in monocytes/macrophages [intracellular, (a–D)] and LL-37 secreted into 
culture media [extracellular, (e–h)] in response to toll-like receptor (TLR) 2/1 elicitation in the absence or presence 10 or 50 nM 1,25(OH)2D3 at 16 h and 24 h. Four 
individuals from a study of healthy South Africans (n = 20) are shown, representing Blacks and Whites of different 25(OH)D3 status [(a,e): 25(OH)D3 sufficient White; 
(B,F): 25(OH)D3-deficient White; (c,g): 25(OH)D3-deficient Black; and (D,h): 25(OH)D3-deficient Black]. Relative protein or peptide level in monocytes/macrophages 
or culture media (enriched for proteins < 50 kDa through ultrafiltration) was quantified and normalized to total protein loaded (dotted line, cathelin; solid line, LL-37). 
Single dashes on blots, between lanes for LL-37 standard and control sample, indicate the position of hCAP-18 (15 kDa), without signaling peptide (3 kDa, not 
detected), and LL-37 (4 kDa) cleaved from cathelin (11 kDa, not detected).
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A7202G, N248S and I602S, and VDR Cdx-2 (Table 1). Similar 
results were obtained for the 1000 Genomes Project’s YRI and 
CEU populations, except for TaqI and BsmI being significant, 
but not ApaI (Table S2 in Supplementary Material). These strik-
ing differences in frequency distribution of disease-associated 
or functionally relevant SNPs support the likelihood of inter-
individual variation in TLR2/1-VDR signaling, response to 
vitamin D supplementation and immune function. For example, 
the two GC SNPs rs7041 and rs4588 create the three common 
Gc/DBP isoforms (Gc1F, Gc1S, and Gc2) showing significant 
geographical- and race-specific distribution patterns. The Gc1F 
alleles (rs7041: T allele, rs4588: C allele) are more common 
among African-Americans and Africans, while the Gc1S alleles 
(rs7041: G allele, rs4588: C allele) are more common among 
Europeans (40, 41). Gc1F and Gc1S have a stronger affinity for 
25(OH)D compared to Gc2 (42), proposed to deliver 25(OH)D 
more efficiently to target tissues (43). Gc1F/Gc1F homozygotes 
have the lowest DBP level and Gc1S/Gc1S the highest, yet the 
bioavailable (unbound or free) 25(OH)D is similar between the 
isoforms (44). Thus, the efficacy of 25(OH)D3 delivery to target 
cells may be influenced by genetics and may contribute to the 
differential response to vitamin D supplementation.
The in vitro model used confirmed the induction of VDR by 
TLR2/1 elicitation (5) and ligand dependance of VDR transac-
tivation of CAMP and CYP24A1 (Figure 3). Observed interac-
tions, regarding race, season and 25(OH)D3 status (Figures 4–6) 
supported the observed correlation between UVI and 25(OH)D3 
status (23), influencing gene expression and hCAP-18 process-
ing; both processes seemingly hampered/delayed in Blacks or 
25(OH)D3 deficient individuals. This was also observed for 
LL-37 secretion in Western blot findings (Figure 7). Significant 
down regulation of VDR protein in Whites in summer likely 
reflected negative auto-regulation (24) or UVI-mediated 
miR125b regulation (20–22).
The relation between VDR methylation and functional 
variables (Table 4) was best observed for VDR protein levels, 
with CpG sites across the enhancer (CGI 1066), promoter (CGI 
1062), exon 3 (CGI 1061) and exon 9 (CGI 1060) showing power 
to discriminate individuals with above average VDR protein 
levels from those with below average levels. This supports, in 
part, the univariate correlation of regional methylation observed 
most commonly with VDR protein (Table 3). The significant, 
large discriminatory power of CGI 1062 CpG 3 in the primary 
promoter of VDR to distinguish a 5.7-fold above average mean 
VDR protein level upon elicitation, may relate to the colocation 
of a binding site for the E2F transcription factor 7, a member 
of the V$E2FF matrix family (Matrix Library 10.0, Genomatix 
2016 (35)), implicated in negative regulation of DNA binding 
and transcription (45). Comparing the V$E2FF matrix to the 
sequence around CGI 1062 CpG 3, showed a matrix and core 
similarity of 1 and 0.875, respectively, with high conservation 
across the CpG 3 cytosine-guanine dinucleotide that forms part 
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TaBle 3 | Significant correlations between independent environmental variables [season (UVI), plasma 25(OH)D3 concentration] and dependent TLR2/1-VDR signaling 
variables, marking VDR expression (VDR mRNA, VDR protein) and function (CAMP mRNA, CYP24A1 mRNA, hCAP-18 protein)a.
UVi circulating 
25(Oh)D3
all gcis cgi 1066 cgi 1062 cgi 1061 cgi 1060 cgi 1060a cgi 1060b
Circulating 
25(OH)D3
 0.396** (71)         
Regional 
methylation
All GCIs ns. ns.        
CGI 1066 ns. ns. 0.478*** (96)
CGI 1062 −0.228* (88) −0.368** (83) 0.552*** (96) ns.
CGI 1061 ns. −0.287** (80) 0.262** (96) −0.399*** (96) 0.341** (97)
CGI 1060 ns. ns. 0.657*** (96) ns. 0.229* (99) 0.327** (97)
CGI 1060a ns. −0.255* (82) 0.338** (96) −0.329** (96) 0.497*** (99) 0.648*** (97) 0.435*** (99)
CGI 1060b ns. 0.298** (81) 0.229* (95) 0.388*** (95) −0.285** (98) −0.458*** (96) 0.269** (98) −0.453*** (98)  
ln VDR  
mRNA
Baseline 0.326** (84) 0.223* (78) ns. ns. ns. ns. ns. ns. ns.
Control 0.273* (84) ns. ns. ns. ns. ns. ns. ns. ns.
1,25(OH)2D3 0.307** (83) 0.274* (77) ns. ns. ns. ns. ns. ns. ns.
TLR2/1 elicitor ns. 0.277* (77) ns. ns. ns. ns. ns. ns. ns.
TLR2/1  
elicitor + 1, 
25(OH)2D3
0.246* (84) 0.233* (78) ns. ns. ns. ns. ns. ns. ns.
VDR protein Baseline −0.276** (87) ns. ns. ns. ns. ns. ns. ns. ns.
Control ns. ns. ns. 0.349** (94) ns. ns. ns. −0.200* (97) 0.206* (96)
1,25(OH)2D3 ns. ns. ns. 0.296** (95) −0.204* (99) ns. ns. −0.317** (98) 0.303** (97)
TLR2/1 elicitor ns. ns. ns. 0.293** (95) −0.227* (99) −0.236* (96) −0.245* (98) −0.348*** (98) 0.201* (97)
TLR2/1  
elicitor + 1, 
25(OH)2D3
ns. ns. ns. 0.336** (95) −0.267** (99) −0.246* (96) ns. −0.362*** (98) 0.364*** (97)
ln CAMP 
mRNA
Baseline ns. ns. ns. ns. ns. ns. ns. ns. ns.
Control 0.249* (83) ns. ns. ns. ns. ns. ns. ns. ns.
1,25(OH)2D3 0.308** (84) ns. ns. −0.268* (91) ns. ns. ns. ns. ns.
TLR2/1 elicitor 0.226* (82) 0.246* (77) ns. ns. ns. ns. ns. ns. ns.
TLR2/1  
elicitor + 1, 
25(OH)2D3
0.249* (84) ns. ns. ns. ns. ns. ns. ns. ns.
ln hCAP-18 
peptide
Baseline −0.216* (87) ns. ns. ns. ns. 0.203* (95) ns. ns. −0.202* (96)
Control −0.214* (88) ns. ns. ns. ns. ns. ns. ns. ns.
1,25(OH)2D3 ns. ns. ns. ns. ns. ns. ns. ns.
TLR2/1 elicitor −0.264* (88) ns. ns. ns. ns. ns. ns. ns. ns.
TLR2/1  
elicitor + 1, 
25(OH)2D3
−0.278** 
(88)
ns. ns. ns. ns. ns. ns. ns. ns.
ln CYP24A1 
mRNA
Baseline ns. ns. ns. ns. ns. ns. ns. ns. ns.
Control ns. ns. ns. ns. ns. ns. ns. ns. ns.
1,25(OH)2D3 ns. ns. ns. ns. ns. ns. ns. ns. ns.
TLR2/1 elicitor ns. ns. ns. −0.251* (91) ns. ns. ns. ns. ns.
TLR2/1  
elicitor + 1, 
25(OH)2D3
ns. ns. ns. ns. ns. ns. ns. ns. ns.
aThe two-tailed Spearman’s rho correlation coefficients were significant at *P < 0.050, **P < 0.010, and ***P < 0.001. The adjusted significance threshold for multiple comparisons is 
**P < 0.010. The number of cases included for each test is shown in brackets next to the correlation coefficient for significant correlations.
CAMP, cathelicidin antimicrobial peptide; CGI, CpG island; CpG, cytosine-phosphate-guanine dinucleotide; CYP24A1, 25-hydroxyvitamin D3-24-hydroxylase; ns, not significant; TLR, 
toll-like receptor; UVI, ultraviolet index; VDR, vitamin D receptor.
of the matrix core. Notably, a CpG-ruinous SNPs (C/G) in the 
second position of the dinucleotide, unique to Africans (5% 
“C,” 1000 Genomes Browser), have been reported. The positive 
correlation between VDR protein level and methylation at CGI 
1062 CpG 3 may support methylation-sensitive suppressor 
activity, alleviated by DNA methylation. The positive impact 
of CGI 1060 CpG 6 methylation, possible only when TaqI is 
“C,” seen for VDR mRNA with supplementation or elicitation, 
support a TB case control finding from our laboratory showing 
concomitant decreased methylation of CGI 1060a associating 
with protection from TB (34) and correlating with increased 
VDR levels in the current study (Table 3). The prominence of 
TaqI-based clustering across all variables and treatments, except 
for hCAP-18, further confirms the importance of this SNP, com-
monly found associated with diverse diseases and first reported 
to be associated with infectious disease by Bellamy et al. (46). 
Pam3CSK4 is a strong activator of NF-κB1 (47) and the negative 
impact of methylation at 1062 CpG 23 on hCAP-18 may relate 
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TaBle  4 | Fold change (above/below average means) and correlation for functional variables, significantly and/or prominently, impacted by VDR methylation, 25(OH)D3, and UVI, together with population clustering, 
observed through score space assessment.
CGI CpG Baseline Control 1,25(OH)2D3 TLR2/1
elicitor
TLR2/1
elicitor +
1,25(OH)2D3
Baseline Control 1,25(OH)2D3 TLR2/1
elicitor
TLR2/1
elicitor +
1,25(OH)2D3
Baseline Control 1,25(OH)2D3 TLR2/1
elicitor
TLR2/1 
elicitor + 
1,25(OH)2D3
Baseline Control 1,25(OH)2D3 TLR2/1
elicitor
TLR2/1 
elicitor + 
1,25(OH)2D3
Baseline Control 1,25(OH)2D3 TLR2/1
elicitor
TLR2/1 
elicitor + 
1,25(OH)2D3
1 1.176 1.556*** 1.574*** 1.454** 1.639*** 0.649**
0.218* (97) 0.349*** (96) 0.339** (97) 0.311** (97) 0.402*** (97) −0.250* (93)
2 1.235* 0.797*
0.218* (97) −0.129 (93)
3 1.324** 1.392*** 1.275* 1.367** 0.819* 0.705*** 0.825*
0.319** (96) 0.315** (97) 0.286** (97) 0.361*** (97) −0.119 (93) −0.286** (93) −0.241* (93)
4 1.307* 1.288* 1.286* 1.313* 0.679***
0.253* (96) 0.212* (97) 0.231* (97) 0.246* (97) −0.225* (93)
5 1.349** 1.315** 1.263* 1.367** 0.763**
0.317** (96) 0.308** (97) 0.277** (97) 0.318** (97) −0.187 (93)
6 1.314* 1.285* 1.163 1.294* 0.791* 0.759* 0.797*
0.275** (96) 0.216* (97) 0.187 (97) 0.204* (97) −0.118 (93) −0.141 (93) −0.177 (93)
7 0.727*
−0.266* (93)
8 0.573 0.614
−0.164 (92) −0.205* (93)
10 0.660 0.650
−0.108 (96) −0.083 (97)
3 1.398 3.411** 3.768** 5.656*** 4.157** 0.472 0.551
0.126 (99) 0.342** (98)
0.384***
(99)
0.425*** (99) 0.400*** (99) −0.252* (98) −0.100 (95)
15 0.672*
−0.277** (94)
18 0.599 0.647 0.653
0.027 (97) 0.014 (98) −0.016 (98)
20 0.645*
−0.321** 
(97)
21 0.615 0.531*
−0.236* 
(97)
−0.327** (98)
23 0.387* 0.370* 0.365*
−0.049 (97) −0.107 (98) −0.093 (98)
37 0.377* 0.507 0.545
−0.090 (93) −0.208* (94) −0.178 (94)
2 1.014*
0.135 (97)
9 0.959** 0.958** 0.964*
−0.271** (98) −0.339** (98)
−0.363*** 
(98)
1 0.933*** 0.940** 0.954*
−0.295** 
(98)
−0.327** (98) −0.320** (98)
2 0.953*** 0.953*** 0.962**
−0.334** 
(98)
−0.405*** (98)
−0.387*** 
(98)
3 0.960** 0.961**
−0.221* (98) −0.276** (98)
4 0.984*
−0.292** (98)
5 0.946*** 0.966*
−0.309** 
(98)
−0.378*** 
(98)
6 1.508* 1.535*
0.099 (93) 0.144 (93)
8 1.029* 1.043**
0.204* (97) 0.346** (97)
13 1.021** 1.016*
0.118 (97) 0.149 (98)
16 1.040* 1.053**
0.237* (98) 0.282** (98)
17 1.061* 1.070* 1.078**
0.202* (97) 0.261** (98) 0.295** (98)
18 1.048**
0.239* (98)
25(OH)D3 1.229* 1.311* 1.255* 1.251* 0.771* 1.333** 1.316**
0.180 (78) 0.274* (77) 0.277* (77) 0.233* (78) −0.207 (82) 0.246* (77) 0.194 (78)
UVI 1.196** 1.186** 1.189**
0.307** (83) 0.202 (83) 0.246* (84)
Race ✓ ✓ ✓ ✓ ✓
IOM status ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
BsmI ✓ ✓ ✓ ✓ ✓ ✓
ApaI ✓ ✓ ✓ ✓ ✓
TaqI ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
S180L ✓ ✓
I602S ✓ ✓ ✓ ✓ ✓
Values are the fold change obtained through OPLS-DA analysis and OPLS verification as well as Spearman Rho's correlation coefficient, significance and n.
Fold change and P-value cutoffs used were either one, or both, ≥1.5-fold or ≤0.667 and P ≤0.050.
*P ≤ 0.050, **P ≤ 0.010 and ***P ≤ 0.001.
Different colors represent the increase (orange) or decrease (blue) in the logarithmic fold change of functional variables as indicated in the color index; scaling the spread of values for each functional variable in thirds, above or below zero. The fold change in VDR protein upon elicitation, discriminated by CGI 1062 CpG 3 was beyond this scale.
-3 -2 -1 1 2 3
ln CYP24A1 mRNA
Methylation 1066
1062
1061
1060
Environment
Score space
assessment
ln VDR mRNA VDR protein ln CAMP mRNA ln hCAP-18 peptide
CAMP, cathelicidin antimicrobial peptide; CGI, CpG island; CpG, cytosine-phosphate-guanine dinucleotide; CYP24A1, 25-hydroxyvitamin D3-24-hydroxylase; ns, not significant; TLR, toll-like receptor; UVI, ultraviolet index; VDR, vitamin D receptor.
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to its location adjacent to an NF-κB1 and SP-1 binding site in 
the primary promoter of VDR.
Overall, it appears that individuals who respond with an 
above average level of VDR protein upon TLR2/1 elicitation 
display hypermethylation at CGI 1066 CpG 1 and 3, as well as 
at CGI 1062 CpG 3, while displaying hypomethylation at CGI 
1061 CpG 9 and CGI 1060a CpG 1-4 (Figure  8). While the 
VDR SNP TaqI and 25(OH)D3 influenced the variation within 
the study population with elicitation, without 1,25(OH)2D3 
supplementation, 25(OH)D3 status was no longer identified 
as a contributing factor upon 1,25(OH)2D3 supplementation. 
Moreover, the effect of several SNPs became apparent only in 
the presence 1,25(OH)2D3 supplementation. This suggests that 
25(OH)D3 status may have a larger effect on TLR2/1, VDR-
mediated signaling than these genetic variables.
FigUre 8 | A schematic diagram summarizing factors influencing the signaling efficacy of the TLR2/1-VDR pathway in response to TLR2/1 elicitation. Pam3CSK4 
(Pam3CysSerLys4), a synthetic tripalmitoylated lipopeptide, mimics the acylated amino terminus of bacterial lipoproteins and is recognized by TLR2, cooperating with 
TLR1 to induce signaling that activates the pro-inflammatory transcription factor NF-κB, inducing CYP27B1 and VDR. Factors found to influence VDR expression 
are indicated in red. UVI correlated with 25(OH)D3, known to autoregulate VDR. Individuals who responded with an above average level of VDR protein upon TLR2/1 
elicitation were hypermethylated at CGI 1066 (CpG 1 and 3) and CGI 1062 (CpG 3), while hypomethylated at CGI 1061 (CpG 9) and CGI 1060 (CpG 1–4). With 
in vitro 1,25(OH)2D3 supplementation CGI 1062 CpG 3 was slightly less discriminatory upon TLR2/1 elicitation, but remained a significant variable to discriminate 
above/below average VDR protein level. However, with supplementation the population clustered by race and all genetic variants indicated (TLR1 SNP I602S, TIRAP 
SNP S180L, and VDR SNPs BsmI, ApaI, and TaqI, see Table 4), compared to clustering by vitamin D status and TaqI alone, without supplementation. Methylation 
at CpG 6 of CGI 1060 (dictated by TaqI, with which it overlaps) together with UVI and circulating 25(OH)D3, significantly discriminated a 1.2-1.5-fold change in VDR 
mRNA with supplement or elicitation. Abbreviations: CAMP, cathelicidin antimicrobial peptide; CGI, CpG island; CpG, cytosine-phosphate-guanine dinucleotide; 
CYP, cytochrome P-450 enzyme; CYP24A1, 25-hydroxyvitamin D3-24-hydroxylase; D2, ergocalciferol; D3, cholecalciferol; DBP, vitamin D binding protein; GC, group 
component or gene encoding DBP; hCAP-18, human cathelicidin antimicrobial peptide 18; LL-37, cathelicidin antimicrobial peptide fragment; 1,25(OH)2D3 
1,25-dihydroxycholecalciferol; 25(OH)D3, 25-hydroxycholecalciferol; NF-κB, nuclear factor kappa B; Pam3CSK4, synthetic tripalmitoylated lipohexapeptide, PTH 
parathyroid hormone; RXR retinoid X receptor; TIRAP, TIR, toll-interleukin 1 receptor domain-containing adaptor protein; TLR, toll-like receptor; UVB, ultraviolet B 
rays; UVI, ultraviolet index; VDR, vitamin D receptor gene; VDR, vitamin D receptor protein; VDRE, vitamin D receptor element.
Taken together, results presented here provide support for 
multifactorial regulation of VDR-mediated TLR2/1 signaling, 
involving interaction between environment, epigenetics, and 
genetics. UVI influences 25(OH)D3 status, which regulates 
VDR expression through VDR methylation, while enhancing 
the extent and rate of VDR transactivation of CAMP encoding 
the antimicrobial peptide hCAP-18. The complex interaction 
between these factors may shed further light on the disparity in 
infectious diseases across the globe.
eThics sTaTeMenT
In accordance with the Declaration of Helsinki, ethical clearance 
was obtained from the South African National Blood Service 
(SANBS) and the Faculty of Science, University of Johannesburg. 
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After informed consent, the SANBS collected blood from ran-
domly selected healthy Black (n = 50; age 17–62 years; 25 males 
and 25 females) and White (n = 50; age 17–69; 25 males and 25 
females) South Africans living in Gauteng, SA.
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